Tosymra Spray
Product Images NDC 70792-812

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Tosymra (NDC 70792-812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tonix Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tosymra 01)

Chemical structure of Sumatriptan, the active ingredient in Tosymra nasal spray. The structure features a sulfonamide group linked to an indole ring and an aminoethyl side chain with dimethyl substitution.*

FDA Label Image

Figure A (Tosymra 02)

An instructional diagram labeled 'Figure A' showing parts of a nasal spray device for Tosymra (Sumatriptan) nasal spray. The diagram identifies the spray nozzle tip designed for insertion into the nose and a plunger area operated by the thumb.*

FDA Label Image

Figure B (Tosymra 03)

An instructional illustration labeled Figure B showing a person holding a cloth or tissue against the back of their neck with both hands. The image focuses on the placement of the hands and cloth at the neck area, likely indicating a step in product use or care.*

FDA Label Image

Figure C (Tosymra 04)

Illustration showing a hand removing a single nasal spray device from an open box containing five devices. The text indicates to remove only one device at a time. This instructional image is related to the Tosymra sumatriptan nasal spray packaging and use.*

FDA Label Image

Figure D (Tosymra 05)

An instructional diagram labeled Figure D showing a hand holding a Tosymra nasal spray and an arrow pointing towards a nasal passage, indicating the direction of administration through the nostril. Adjacent to the diagram is a boxed area for lot and expiration date information.*

FDA Label Image

Figure E (Tosymra 06)

An instructional illustration showing hands handling the Tosymra nasal spray packaging. It demonstrates flipping over a blister pack to remove the spray device, then holding the device with a finger loop for use. The figure is labeled as 'Figure E.'*

FDA Label Image

Figure F (Tosymra 07)

An instructional diagram showing the proper positioning of the Tosymra nasal spray device near a nostril for administration. The illustration includes an arrow indicating the direction to insert the spray nozzle into the nostril.*

FDA Label Image

Figure G (Tosymra 08)

An instructional diagram labeled Figure G showing a person inserting a finger into one nostril, likely demonstrating the proper use technique for a nasal spray.*

FDA Label Image

Figure H-i (Tosymra 09)

An instructional diagram showing a hand holding a nasal spray device and demonstrating the correct technique, with an arrow indicating the spray nozzle should be angled outward.*

FDA Label Image

Figure J (Tosymra 10)

An instructional diagram showing a person tilting their head back slightly while inserting a nasal spray in one nostril. Arrows indicate the direction to tilt the head and the nasal spray device being positioned for use. This figure illustrates the proper technique for administering a nasal spray.*

FDA Label Image

Figure K (Tosymra 11)

An instructional illustration showing how to use a nasal spray. The image directs the user to press the plunger up on the spray device and then breathe in through the nose to receive the spray.*

FDA Label Image

Figure L (Tosymra 12)

An instructional illustration showing a side profile of a person using a nasal spray. Arrows indicate inhaling through the nose and exhaling through the mouth. A clock icon displays "10 to 20 Sec" to suggest timing. Text advises to gently breathe in through the nose and out through the mouth.*

FDA Label Image

Figure M (Tosymra 13)

An instructional illustration showing a hand discarding a used nasal spray device into a waste container labeled "Household Trash." The image visually demonstrates proper disposal of a nasal spray applicator, relevant to products like Tosymra (Sumatriptan) nasal spray.*

FDA Label Image

Principal Display Panel (10 mg Bottle Blister Pack Carton)

Packaging label for Tosymra (sumatriptan nasal spray) 10 mg by Tonix Medicines, Inc. The box indicates it contains six unit-dose nasal spray devices, each delivering 10 mg of sumatriptan in 0.1 mL. The label includes storage instructions, a barcode, and dosage form as nasal spray for intranasal use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.